Uroplasty, Inc. (UPI) Tops Q2 EPS by 2c
Uroplasty, Inc. (NASDAQ: UPI) reported Q2 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $5 million versus the consensus estimate of $4.93 million.
You May Also Be Interested In
- NCI Building Systems (NCS) Tops Q4 EPS by 3c; Issues Outlook
- Ocean Power Technologies (OPTT) Posts Q2 Loss of 31c/Share
- Hovnanian Enterprises Inc. (HOV) Tops Q4 EPS by 5c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!